Literature DB >> 9640454

Acute psychosis in a trauma patient due to ciprofloxacin.

E A James1, A Z Demian.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9640454      PMCID: PMC2360825          DOI: 10.1136/pgmj.74.869.189

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  7 in total

1.  Ciprofloxacin induced psychosis.

Authors:  L K Meher; D Tripathy; S Acharya
Journal:  J Assoc Physicians India       Date:  1992-06

2.  [Psychotic reaction following administration of indomethacin and ciprofloxacin].

Authors:  J D Orón; J Ivorra; J Portilla; J Esteve
Journal:  Rev Clin Esp       Date:  1992-11       Impact factor: 1.556

3.  Assessment of the effects of ciprofloxacin and nalidixic acid on cerebral blood flow and metabolism in healthy subjects by positron emission tomography.

Authors:  E M Bednarczyk; L P Adler; B Remler; P Goyer; M Wiznitzer; G P Leisure; D Little; F Miraldi
Journal:  Pharmacotherapy       Date:  1994 Mar-Apr       Impact factor: 4.705

4.  A patch clamp study of the effects of ciprofloxacin and biphenyl acetic acid on rat hippocampal neurone GABAA and ionotropic glutamate receptors.

Authors:  R F Halliwell; P G Davey; J J Lambert
Journal:  Neuropharmacology       Date:  1995-12       Impact factor: 5.250

5.  Possible interaction of fluoroquinolones with the benzodiazepine-GABAA-receptor complex.

Authors:  E Unseld; G Ziegler; A Gemeinhardt; U Janssen; U Klotz
Journal:  Br J Clin Pharmacol       Date:  1990-07       Impact factor: 4.335

6.  Ciprofloxacin-induced acute psychosis.

Authors:  J P Mulhall; L S Bergmann
Journal:  Urology       Date:  1995-07       Impact factor: 2.649

7.  Ciprofloxacin-induced psychosis.

Authors:  R R Reeves
Journal:  Ann Pharmacother       Date:  1992 Jul-Aug       Impact factor: 3.154

  7 in total
  1 in total

Review 1.  Quinolones: review of psychiatric and neurological adverse reactions.

Authors:  Ana M Tomé; Augusto Filipe
Journal:  Drug Saf       Date:  2011-06-01       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.